Jeroen van de Pol

147 5 Preferences of patients regarding community pharmacy services: A discrete choice experiment Class 1 n=822 Class 2 n=351 Attribute Level Utility (SE) RI Utility (SE) RI Communication with pharmacy team Face-2-face, by telephone and online 0.6 (0.003) 15.9% 0.12 (0.005) 13.8% Medication record On paper and online 1.58 (0.007) 41.9% 0.1 (0.012) 11.5% Class 3 n=425 Class 4 n=864 Drugs for minor ailments Also prescription drugs 1.3 (0.008) 34.1% 0.07 (0.01) 2.0% Pharmacogenetics Advice regarding pharmacogenetics 0.51 (0.008) 13.4% 1.08 (0.008) 31.3% Point-of-care-testing Offers tests 0.73 (0.009) 19.2% 1.0 (0.009) 29.0% Track & Trace Provides track & trace 0.52 (0.005) 13.6% 0.35 (0.005) 10.1% Communication with pharmacy team Face-2-face, by telephone and online 0.16 (0.004) 4.2% 0.33 (0.005) 9.6% Medication record On paper and online 0.59 (0.01) 15.5% 0.62 (0.01) 18.0% For sake of readability, and the attributes always containing two levels, only the level with the additional service is showed. The level without the additional service is always the inverse compared to the level with the additional service. All attributes significantly contribute to the model. The results show that class 1 (n=822, 33.4%) predominantly prefers community pharmacies an online medication record (utility of 1.58 and RI of 41.9%). Class 2 disfavors predominantly community pharmacies offering prescription drugs for minor ailments (utility of -0.31 and RI of 35.6%). Class 3 predominantly prefers community pharmacies offering prescription drugs for minor ailments (utility of 1.3 and RI of 34.1%). Class 4 mostly prefers community pharmacies offering pharmacogenetic testing (utility of 1.08 and RI of 31.3%). Background characteristics of participants in each class are presented in table 3, with class 3 containing more males compared to other classes and class 4 consisting of participants who more often regard the community pharmacist as a healthcare provider compared to other classes.